Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia

Br J Haematol. 2008 Sep;142(5):852-3. doi: 10.1111/j.1365-2141.2008.07247.x. Epub 2008 May 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Aminoglycosides / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage*
  • Female
  • Gemtuzumab
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / surgery
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Aminoglycosides
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Gemtuzumab